Otsuka Pharmaceutical Signs Joint Development Pact With Korean Dong-A
This article was originally published in PharmAsia News
Executive Summary
Japanese drug maker Otsuka Pharmaceutical and Dong-A Pharmaceutical of Korea March 30 signed a partnership agreement to jointly research and development new drugs. According to the agreement, the two will cooperate in pharmaceutical R&D and clinic trials. Currently, Otsuka and Dong-A are cooperating in manufacturing and marketing beverage products in Korea. (Click here for more - Japanese language